{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:49:53Z","timestamp":1789526993555,"version":"build-2803163510"},"publisher-location":"Boston, MA","reference-count":86,"publisher":"Springer US","isbn-type":[{"value":"9781461356356","type":"print"},{"value":"9781461516019","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001]]},"DOI":"10.1007\/978-1-4615-1601-9_3","type":"book-chapter","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T05:09:38Z","timestamp":1305868178000},"page":"75-88","source":"Crossref","is-referenced-by-count":18,"title":["HTLV-I Associated Leukemia\/Lymphoma: Epidemiology, Biology, and Treatment"],"prefix":"10.1007","author":[{"given":"Richard","family":"Siegel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Gartenhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Kuzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"3_CR1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","volume":"50","author":"T Uchiyama","year":"1977","unstructured":"Uchiyama T Yodoi J, Sagawa K, et al: Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50:481\u2013492, 1977","journal-title":"Blood"},{"key":"3_CR2","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, et al: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci 77:7415\u20137419, 1980","journal-title":"Proc Natl Acad Sci"},{"key":"3_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1365-4362.1990.tb03791.x","volume":"29","author":"DJ Gross","year":"1990","unstructured":"Gross DJ, Kavanaugh A: HTLV-I. Int J Dermatol 29:161\u2013165, 1990","journal-title":"Int J Dermatol"},{"key":"3_CR4","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/S0140-6736(98)09460-4","volume":"353","author":"A Manns","year":"1999","unstructured":"Manns A, Hisada M, La Grenade L: Human T-lymphotropic virus type I infection. Lancet 353:1951\u20131958, 1999","journal-title":"Lancet"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1046\/j.1365-2141.1998.00582.x","volume":"100","author":"R Pawson","year":"1998","unstructured":"Pawson R, Mufti GJ, Pagliuca A: Management of adult T-cell leukaemia,lymphoma. Br J Hematol 100:453\u2013458, 1998","journal-title":"Br J Hematol"},{"key":"3_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0140-6736(94)90994-6","volume":"343","author":"K Yamaguchi","year":"1994","unstructured":"Yamaguchi K: Human T-lymphotropic virus type I in Japan. Lancet 343:213\u2013216, 1994","journal-title":"Lancet"},{"issue":"S1","key":"3_CR7","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1097\/00042560-199600001-00004","volume":"13","author":"K Takatsuki","year":"1996","unstructured":"Takatsuki K, Matsuoka M, Yamaguchi K: Adult T-Cell Leukemia in Japan.. J Acquir Immune Defic Synch Hum Retrovirol 13(S1):S15\u201319, 1996","journal-title":"J Acquir Immune Defic Synch Hum Retrovirol"},{"issue":"S1","key":"3_CR8","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/00042560-199600001-00002","volume":"13","author":"N Mueller","year":"1996","unstructured":"Mueller N, Okayama A, Stuver S, et al: Findings from the Miyazaki cohort study. J Acquir Immune Defic Syndr Hum Retrovirol 13(S1):S2\u2013S7, 1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"S1","key":"3_CR9","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1097\/00042560-199600001-00003","volume":"13","author":"GP Taylor","year":"1996","unstructured":"Taylor GP: The epidemiology of HTLV-I in Europe.. J Acquir Immune Defic Syndr Hum Retrovirol 13(S1):S8\u2013S14, 1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"S1","key":"3_CR10","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1097\/00042560-199600001-00005","volume":"13","author":"B Hanchard","year":"1996","unstructured":"Hanchard B: Adult T-cell leukemia,lymphoma in Jamaica: 1986\u20131995. J Acquir Immune Defic Syndr Hum Retrovirol 13(S1):S20\u2013S25, 1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"3_CR11","first-page":"337","volume-title":"T-Lymphoma associated with HTLV-I outside the Caribbean and Japan","author":"N Tubiana","year":"1985","unstructured":"Tubiana N, Lejeune C, Lecaer F, et al: T-Lymphoma associated with HTLV-I outside the Caribbean and Japan. Lancet:337, 1985"},{"key":"3_CR12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7326\/0003-4819-106-3-361","volume":"106","author":"WN Gibbs","year":"1987","unstructured":"Gibbs WN, Lofters WS, Campbell M, et al: Non-Hodgkin Lymphoma in Jamaica and its relation to adult T-cell Leukemia,lymphoma. Ann Intern Med 106:361\u2013368, 1987","journal-title":"Ann Intern Med"},{"key":"3_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/00042560-199606010-00014","volume":"12","author":"JE Kaplan","year":"1996","unstructured":"Kaplan JE, Khabbaz RF, Murphy EL, et al: Male-to-female transmission of human T-cell lymphotropic virus types I and H: Association with viral load. J Acquir Immune Defic Syndr Hum Retrovirol 12:193\u2013201, 1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/00042560-199606010-00013","volume":"12","author":"PN Nyambi","year":"1996","unstructured":"Nyambi PN, Ville Y, Louwagie J, et al: Mother-to-child transmission of human T-cell lymphotropic virus types I and II (HTLV-I,II) in Gabon: A prospective follow-up of 4 years. J Acquir Immune Defic Synch Hum Retrovirol 12:187\u2013192, 1996","journal-title":"J Acquir Immune Defic Synch Hum Retrovirol"},{"key":"3_CR15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0140-6736(83)92613-2","volume":"i","author":"A Komuro","year":"1983","unstructured":"Komuro A, Hayami M, Fujii H, et al: Vertical transmission of adult T-cell leukaemia virus. Lancet i:240, 1983","journal-title":"Lancet"},{"key":"3_CR16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood.V74.1.388.388","volume":"74","author":"YC Chen","year":"1989","unstructured":"Chen YC, Wang CH, Su IJ, et al: Infection of human T-cell leukemia virus type I and development of human T-cell leukemia,lymphoma in patients with hematologic neoplasms: A possible linkage to blood transfusion. Blood 74:388\u2013394, 1989","journal-title":"Blood"},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/S0140-6736(95)90721-1","volume":"345","author":"J Giesecke","year":"1995","unstructured":"Giesecke J: HTLV screening of Swedish blood donors. Lancet 345:978, 1995","journal-title":"Lancet"},{"key":"3_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0140-6736(86)91636-3","volume":"ii","author":"M Osame","year":"1986","unstructured":"Osame M, Izumo S, Igata A, et al: Blood transfusion and HTLV-I associated myelopathy. Lancet ii:104\u2013105, 1986","journal-title":"Lancet"},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1136\/bmj.307.6914.1235","volume":"307","author":"M Brennan","year":"1993","unstructured":"Brennan M, Runganga J, Barbara JA, et al: Prevalence of antibodies to human T cell leukaemia,lymphoma virus in blood donors in north London. Br Med J 307:1235\u20131239, 1993","journal-title":"Br Med J"},{"key":"3_CR20","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1136\/bmj.307.6914.1224","volume":"307","author":"AG Dalgleish","year":"1993","unstructured":"Dalgleish AG: Human T-cell leukaemia,lymphoma virus and blood donation. Br Med J 307:1224\u20131225, 1993","journal-title":"Br Med J"},{"key":"3_CR21","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/0140-6736(90)91177-C","volume":"335","author":"J Coste","year":"1990","unstructured":"Coste J, Lemaire JM, Barin F, et al: HTLV-I,II antibodies in French blood donors. Lancet 335:1167\u20131168, 1990","journal-title":"Lancet"},{"issue":"S1","key":"3_CR22","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1097\/00042560-199600001-00012","volume":"13","author":"M Yoshida","year":"1996","unstructured":"Yoshida M: Molecular biology of HTLV-I: Recent progress. J Acquir Immune Defic Synch Hum Retrovirol 13(S1):S63\u2013S68, 1996","journal-title":"J Acquir Immune Defic Synch Hum Retrovirol"},{"key":"3_CR23","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1182\/blood.V86.10.3619.bloodjournal86103619","volume":"86","author":"G Franchini","year":"1995","unstructured":"Franchini G: Molecular mechanisms of human T-cell leukemia,lymphotropic virus type I infection. Blood 86:3619\u20133639, 1995","journal-title":"Blood"},{"key":"3_CR24","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1182\/blood.V82.9.2823.2823","volume":"82","author":"K Nagafuji","year":"1993","unstructured":"Nagafuji K, Harada M, Teshima T, et al: Hematopoietic progenitor cells from patients with adult T-cell leukemia-lymphoma are not infected with human T-cell leukemia virus type 1. Blood 82:2823\u20132828, 1993","journal-title":"Blood"},{"key":"3_CR25","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1073\/pnas.86.9.3351","volume":"86","author":"R Grassman","year":"1989","unstructured":"Grassman R, Dengler C, Muller-Fleckenstein I, et al: Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector. Proc Natl Acad Sci 86:3351\u20133355, 1989","journal-title":"Proc Natl Acad Sci"},{"key":"3_CR26","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/j.1460-2075.1996.tb00505.x","volume":"15","author":"T Suzuki","year":"1996","unstructured":"Suzuki T, Kitao S, Matsushime H, et al: HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p164Aand counteracts its inhibitory activity towards CDK4. EMBO 15:1607\u20131614, 1996","journal-title":"EMBO"},{"issue":"S 1","key":"3_CR27","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1097\/00042560-199600001-00013","volume":"13","author":"A Cereseto","year":"1996","unstructured":"Cereseto A, Mulloy JC, Franchini G: Insights on the pathogenicity of human Tlymphotropic,leukemia virus types I and II. J Acquir Immune Defic Syndr 13(S 1):S69\u2013S75, 1996","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3_CR28","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1182\/blood.V92.10.3557","volume":"92","author":"M Hisada","year":"1998","unstructured":"Hisada M, Okayama A, Shiryo S, et al: Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I. Blood 92:3557\u20133561, 1998","journal-title":"Blood"},{"key":"3_CR29","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1182\/blood.V85.7.1865.bloodjournal8571865","volume":"85","author":"Y Furukawa","year":"1995","unstructured":"Furukawa Y, Osame M, Kubota R, et al: Human T-cell leukemia virus type-1 (HTLV-1) tax is expressed at the same level in infected cells of HTLV-1-associated myelopathy or tropical spastic paraphrases patients as in asymptomatic carriers but at a lower level in adult T-cell leukemia cells. Blood 85:1865\u20131870, 1995","journal-title":"Blood"},{"key":"3_CR30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1182\/blood.V66.1.120.120","volume":"66","author":"K Kinoshita","year":"1985","unstructured":"Kinoshita K, Amagaski T, Ikeda S, et al: Preleukemic state of adult T-cell leukemia: Abnormal T lymphocytosis induced by human adult T-cell leukemia-lymphoma virus. Blood 66:120\u2013127, 1985","journal-title":"Blood"},{"key":"3_CR31","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/0140-6736(91)92413-V","volume":"338","author":"B Hanchard","year":"1991","unstructured":"Hanchard B, LaGrenade L, Carberry C, et al: Childhood infective dermatitis evolving into adult T-cell leukaemia after 17 years. Lancet 338:1593\u20131594, 1991","journal-title":"Lancet"},{"key":"3_CR32","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/jnci\/90.8.617","volume":"90","author":"A Manns","year":"1998","unstructured":"Manns A, Hanchard B, Morgan OS, et al: Human leukocyte antigen class II alleles associated with human T-cell lymphotropic virus type I infection and adult T-cell leukemia,lymphoma in a black population. J Nail Cancer Inst 90:617\u2013622, 1998","journal-title":"J Nail Cancer Inst"},{"key":"3_CR33","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/S0301-472X(99)00053-3","volume":"27","author":"N Arima","year":"1999","unstructured":"Arima N, Matsushita K, Obata H, et al: NF-KB involvement in the activation of primary adult T-cell leukemia cells and its clinical implications. Exp Hem 27:1168\u20131175, 1999","journal-title":"Exp Hem"},{"key":"3_CR34","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"Shimoyama M, and members of the Lymphoma Study Group","year":"1991","unstructured":"Shimoyama M, and members of the Lymphoma Study Group: Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. Br J Hem 79:428\u2013437, 1991","journal-title":"Br J Hem"},{"key":"3_CR35","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood.V84.9.3080.3080","volume":"84","author":"S Takemoto","year":"1994","unstructured":"Takemoto S, Matsuoka M, Yamaguchi K, et al: A novel diagnostic method of adult T-cell leukemia: Monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction. Blood 84:3080\u20133085, 1994","journal-title":"Blood"},{"key":"3_CR36","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJM198308043090501","volume":"309","author":"PA Bunn","year":"1983","unstructured":"Bunn PA, Schecter GP, Jaffe E, et al: Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. N Engl J Med 309:257\u2013264, 1983","journal-title":"N Engl J Med"},{"key":"3_CR37","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/1097-0142(19850215)55:4<851::AID-CNCR2820550424>3.0.CO;2-J","volume":"55","author":"F Kawano","year":"1985","unstructured":"Kawano F, Yamaguchi K, Nishimura H, et al: Variation in the clinical courses of adult T-cell leukemia. Cancer 55:851\u2013856, 1985","journal-title":"Cancer"},{"key":"3_CR38","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1136\/bmj.297.6661.1456","volume":"297","author":"A Pagliuca","year":"1988","unstructured":"Pagliuca A, Layton DM, Allen S, et al: Hyperinfection with strongyloides after treatment for adult T-cell leukaemia-lymphoma in an African immigrant. Br Med J 297:1456\u20131457, 1988","journal-title":"Br Med J"},{"key":"3_CR39","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/0140-6736(91)90929-J","volume":"337","author":"H Taguchi","year":"1991","unstructured":"Taguchi H, Kobayashi M, Miyoshi I: Immunosuppression by HTLV-I infection. Lancet 337:308, 1991","journal-title":"Lancet"},{"key":"3_CR40","first-page":"81090","volume":"15","author":"Lymphoma Study Group","year":"1991","unstructured":"Lymphoma Study Group: Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Leuk Res 15:81090, 1991","journal-title":"Leuk Res"},{"key":"3_CR41","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1200\/JCO.1988.6.7.1088","volume":"6","author":"M Shimoyama","year":"1988","unstructured":"Shimoyama M, Ota K, Kikuchi M, et al: Major prognostic factors of adult patients with advanced T-cell lymphoma,leukemia. J Clin Oncol 6:1088\u20131097, 1988","journal-title":"J Clin Oncol"},{"key":"3_CR42","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1002\/1097-0142(19910515)67:10<2605::AID-CNCR2820671034>3.0.CO;2-L","volume":"67","author":"Y Yamada","year":"1991","unstructured":"Yamada Y, Murata K, Kamihira S, et al: Prognostic significance of the proportion of Ki-67-positive cells in adult T-cell leukemia. Cancer 67:2605\u20132609, 1991","journal-title":"Cancer"},{"key":"3_CR43","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0145-2126(92)90168-7","volume":"16","author":"S Kamihira","year":"1992","unstructured":"Kamihira S, Sohda H, Atogami S, et al: Phenotypic diversity and prognosis of adult T-cell leukemia. Leuk Res 16:435\u2013441, 1992","journal-title":"Leuk Res"},{"key":"3_CR44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0145-2126(91)90089-C","volume":"15","author":"N Sadamori","year":"1991","unstructured":"Sadamori N, Ikeda S, Yamaguchi K, et al: Serum deoxythymidine kinase in adult T-cell leukemia-lymphoma and its related disorders. Leuk Res 15:99\u2013103, 1991","journal-title":"Leuk Res"},{"key":"3_CR45","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1002\/1097-0142(19940601)73:11<2753::AID-CNCR2820731117>3.0.CO;2-X","volume":"73","author":"S Kamihira","year":"1994","unstructured":"Kamihira S, Atogami S, Sohda H, et al: Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia. Cancer 73:2753\u20132758, 1994","journal-title":"Cancer"},{"key":"3_CR46","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.V89.3.948","volume":"89","author":"K Tsukasaki","year":"1997","unstructured":"Tsukasaki K, Tsushima H, Yamamura M, et al: Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: Frequent clonal change at crisis from indolent disease. Blood 89:948\u2013956, 1997","journal-title":"Blood"},{"key":"3_CR47","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/10428199909167395","volume":"32","author":"Y Hayami","year":"1999","unstructured":"Hayami Y, Komatsu H, lida S, et al: Microsattelite instability as a potential marker for poor prognosis in adult T-cell leukemia,lymphoma. Leukemia & Lymphoma 32:345\u2013349, 1999","journal-title":"Leukemia & Lymphoma"},{"issue":"S1","key":"3_CR48","doi-asserted-by":"publisher","first-page":"S146","DOI":"10.1097\/00042560-199600001-00023","volume":"13","author":"B Renjifo","year":"1996","unstructured":"Renjifo B, Chou K, Ramirez LS, et al: Human T-cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome. J Acquir Immune Defic Syndr Hum Retrovirol 13(S1):S146\u2013S153, 1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"3_CR49","first-page":"746","volume":"87","author":"SA Peter","year":"1995","unstructured":"Peter SA, Cervantes JF: Hypercalcemia associated with adult T-cell leukemia,lymphoma (ATL). J Nall Med Assoc. 87:746\u2013748, 1995","journal-title":"J Nall Med Assoc"},{"key":"3_CR50","first-page":"166","volume":"21","author":"K Ikeda","year":"1995","unstructured":"Ikeda K, Inoue D, Okazaki R, et al: Parathyroid hormone-related peptide in hypercalcemia associated with adult T cell leukemia,lymphoma: Molecular and cellular mechanism of parathyroid hormone-related peptide overexpression in HTLV-Iinfected T cells. Miner Electrolyte Metab 21:166\u2013170, 1995","journal-title":"Miner Electrolyte Metab"},{"key":"3_CR51","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1001\/archinte.1986.00360220125022","volume":"146","author":"RC Dodd","year":"1986","unstructured":"Dodd RC, Winkler CF, Williams ME, et al: Calcitriol levels in hypercalcemic patients with adult T-cell lymphoma. Arch Intern Med 146:1971\u20131972, 1986","journal-title":"Arch Intern Med"},{"key":"3_CR52","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1001\/archinte.1988.00380040161023","volume":"148","author":"S Fukumoto","year":"1988","unstructured":"Fukumoto S, Matsumoto T, Ikeda K, et al: Clinical evidence of calcium metabolism in adult T-cell leukemia,lymphoma. Arch Intern Med 148:921\u2013925, 1988","journal-title":"Arch Intern Med"},{"key":"3_CR53","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-111-6-484","volume":"111","author":"T Motokura","year":"1989","unstructured":"Motokura T, Fukumoto S, Matsumoto T, et al: Parathyroid hormone-related protein in adult T-cell leukemia,lymphoma. Ann Intern Med 111:484\u2013488, 1989","journal-title":"Ann Intern Med"},{"key":"3_CR54","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1210\/jc.79.5.1322","volume":"79","author":"K Ikeda","year":"1994","unstructured":"Ikeda K, Ohno H, Hane M, Yokoi H, et al: Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: Evidence for elevated levels in plasma from patients with adult T-cell leukemia,lymphoma and B-cell lymphoma. J Clin Endocrinol Metab 79:1322\u20131327, 1994","journal-title":"J Clin Endocrinol Metab"},{"key":"3_CR55","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0021-9258(18)54056-4","volume":"268","author":"K Ikeda","year":"1993","unstructured":"Ikeda K, Okazaki R, Inoue D, et al: Transcription of the gene for parathyroid hormone-related peptide from the human is activated through a cAMP-dependent pathway by prostaglandin E, in HTLV-I-infected T cells. J Biol Chem 268:1174\u20131179, 1993","journal-title":"J Biol Chem"},{"key":"3_CR56","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1210\/en.132.6.2551","volume":"132","author":"K Ikeda","year":"1993","unstructured":"Ikeda K, Okazaki R, Inoue D, et al: Interleukin-2 increases production and secretion of parathyroid hormone-related peptide by human T cell leukemia virus type I-infected T cells: Possible role in hypercalcemia associated with adult T-cell leukemia. Endocrinol 132:2551\u20132556, 1993","journal-title":"Endocrinol"},{"key":"3_CR57","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood.V81.4.1017.1017","volume":"81","author":"E Ejima","year":"1993","unstructured":"Ejima E, Rosenblatt J, Massari M, et al: Cell-type-specific transactivation of the parathyroid hormone-related protein gene promoter by the human T-cell leukemia virus type I (HTLV-I) tax and HTLV-II tax proteins. Blood 81:1017\u20131024, 1993","journal-title":"Blood"},{"key":"3_CR58","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1084\/jem.172.3.759","volume":"172","author":"T Watanabe","year":"1990","unstructured":"Watanabe T, Yamaguchi K, Takatsuki K, et al: Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type I (HTLV-I) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-I tax gene. J Exp Med 172:759\u2013765, 1990","journal-title":"J Exp Med"},{"key":"3_CR59","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1128\/JVI.67.10.6087-6095.1993","volume":"67","author":"J Dittmer","year":"1993","unstructured":"Dittmer J, Gitlin S, Reid R, et al: Transactivation of the P2 promoter of parathyroid hormone-related protein by human T-cell lymphotropic virus type I tax,: Evidence for the involvement of transcription factor etsl. J Virol 67:6087\u20136095, 1993.","journal-title":"J Virol"},{"key":"3_CR60","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/00042560-199606010-00012","volume":"12","author":"H Taguchi","year":"1996","unstructured":"Taguchi H, Kinoshita KI, Takatsuki K, et al: An intensive chemotherapy of adult T-cell leukemia,lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support. J Acquir Immune Defic Syndr Hum Retrovirol 12:182\u2013186, 1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"3_CR61","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1182\/blood.V81.10.2810.2810","volume":"81","author":"JA Sparano","year":"1993","unstructured":"Sparano JA, Wiernik PH, Strack M, et al: Infusional cyclophoshamide, doxorubicin, and etoposide in human immunodeficiency virus-, and human T-cell leukemia virus type I-related non-Hodgkin\u2019s lymphoma: A highly active regimen. Blood 81:2810\u20132815, 1993","journal-title":"Blood"},{"key":"3_CR62","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/bjc.1994.394","volume":"70","author":"H Tsuda","year":"1994","unstructured":"Tsuda H, Takatsuki K, Ohno R, et al: Treatment of adult T-cell leukemia-lymphoma with irinotecan hydrochloride (CPT-11). Br J Cancer 70:771\u2013774, 1994","journal-title":"Br J Cancer"},{"key":"3_CR63","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0140-6736(92)91052-A","volume":"339","author":"F Brito-Babapulle","year":"1992","unstructured":"Brito-Babapulle F, Arya R, Griffiths T, et al: BEAM regimen and G-CSF in HTLV-I-associated T-cell lymphoma. Lancet 339:133\u2013134, 1992","journal-title":"Lancet"},{"key":"3_CR64","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1002\/1097-0142(19871201)60:11<2605::AID-CNCR2820601104>3.0.CO;2-T","volume":"60","author":"W Lofters","year":"1987","unstructured":"Lofters W, Campbell M, Gibbs N, et al: 2\u2019-Deoxycoformycin therapy in adult T-cell leukemia,lymphoma. Cancer 60:2605\u20132608, 1987","journal-title":"Cancer"},{"key":"3_CR65","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/0145-2126(86)90251-1","volume":"10","author":"K Yamaguchi","year":"1996","unstructured":"Yamaguchi K, Yul LS, Oda T, et al: Clinical consequences of 2\u2019-deoxycoformycin treatment in patients with refractory adult T-cell leukemia. Leuk Res 10:989\u2013993, 1996","journal-title":"Leuk Res"},{"key":"3_CR66","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1002\/1097-0142(19930401)71:7<2217::AID-CNCR2820710709>3.0.CO;2-8","volume":"71","author":"R Olmo","year":"1993","unstructured":"Olmo R, Masaoka T, Shirakawa S, et al: Treatment of adult T-cell leukemia,lymphoma with MST-16, a new oral antitumor drug and a derivative of Bis (2,6-dioxopiperazine). Cancer 71:2217\u20132221, 1993","journal-title":"Cancer"},{"key":"3_CR67","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0145-2126(93)90061-O","volume":"17","author":"K Tsukasaki","year":"1993","unstructured":"Tsukasaki K, Ikeda S, Murata K, et al: Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia,lymphoma. Leuk Res 17:157\u2013166, 1993","journal-title":"Leuk Res"},{"key":"3_CR68","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1046\/j.1365-2141.1996.02338.x","volume":"94","author":"A Borg","year":"1996","unstructured":"Borg A, Yin JA, Johnson PR, et al: Successful treatment of HTLV-I-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation. Br J Hematol 94:713\u2013715, 1996","journal-title":"Br J Hematol"},{"key":"3_CR69","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2141.1994.tb05040.x","volume":"88","author":"P Ljungman","year":"1994","unstructured":"Ljungman P, Lawler M, Asjo B, et al: Infection of donor lymphocytes with human T lymphotropic virus type 1 (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia. Br J Hematol 88:403\u2013405, 1994","journal-title":"Br J Hematol"},{"key":"3_CR70","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/j.1365-2141.1995.tb08399.x","volume":"89","author":"I Miyoshi","year":"1995","unstructured":"Miyoshi I, Murata N, Machida H, et al: Transmission of human T-lymphotropic virus type 1 by bone marrow transplantation. Br J Hematol 89:690\u2013691, 1995","journal-title":"Br J Hematol"},{"key":"3_CR71","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1182\/blood.V76.10.2065.2065","volume":"76","author":"Y Kuwazuru","year":"1990","unstructured":"Kuwazuru Y, Hanada S, Furukawa T, et al: Expression of P-glycoprotein in adult T-cell leukemia cells. Blood 76:2065\u20132071, 1990","journal-title":"Blood"},{"key":"3_CR72","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","volume":"332","author":"PS Gill","year":"1995","unstructured":"Gill PS, Harrington W, Kaplan MH, et al: Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med 332:1744\u20131748, 1995","journal-title":"N Engl J Med"},{"issue":"1","key":"3_CR73","doi-asserted-by":"publisher","first-page":"S186","DOI":"10.1097\/00042560-199600001-00028","volume":"13","author":"A Bazarbachi","year":"1996","unstructured":"Bazarbachi A, Hermine O: Treatment with a combination of zidovudine and a-interferon in na\u00efve and pretreated adult T-cell leukemia,lymphoma patients. J Acquir Immune Defic Syndr Hum Retrovirol 13 (S 1): S 186\u2013S190, 1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"3_CR74","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJM199506293322604","volume":"332","author":"O Hermine","year":"1995","unstructured":"Hermine O, Bouscary D, Gessain A, et al: Brief report: Treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N Engl J Med 332:1749\u20131751, 1995","journal-title":"N Engl J Med"},{"key":"3_CR75","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S0190-9622(99)70543-8","volume":"40","author":"EF Chan","year":"1999","unstructured":"Chan EF, Dowdy YG, Lee B, et al: A novel chemotherapeutic (interferon alfa, zidovudine, and etretinate) for adult T-cell lymphoma resulting in rapid tumor destruction. J Amer Acad Dermatol 40:116\u2013121, 1999","journal-title":"J Amer Acad Dermatol"},{"key":"3_CR76","first-page":"2540","volume":"5","author":"J Dierov","year":"1999","unstructured":"Dierov J, Sawaya B, Prosniak M, et al: Retinoic acid modulates a bimodal effect n cell cycle progression in human adult T-cell leukemia cells. Clin Cancer Res 5:2540\u20132547, 1999","journal-title":"Clin Cancer Res"},{"key":"3_CR77","doi-asserted-by":"publisher","first-page":"31723","DOI":"10.1074\/jbc.271.49.31723","volume":"271","author":"M Liu","year":"1996","unstructured":"Liu M, Iavarone A, Freedman L: Transcriptional activation of the human p21WAFICIPIgene by retinoic acid receptor. J Biol Chem 271:31723\u201331728, 1996","journal-title":"J Biol Chem"},{"key":"3_CR78","doi-asserted-by":"publisher","first-page":"12070","DOI":"10.1073\/pnas.94.22.12070","volume":"94","author":"J Langenfeld","year":"1997","unstructured":"Langenfeld J, Kiyokawa H, Sekula D, et al: Posttranslational regulation of cyclin D1 by retinoic acid: A chemoprevention mechanism. Proc Natl Acad Sci 94:12070\u201312074, 1997","journal-title":"Proc Natl Acad Sci"},{"key":"3_CR79","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/1097-0142(19870315)59:6<1059::AID-CNCR2820590602>3.0.CO;2-M","volume":"59","author":"K Tamura","year":"1987","unstructured":"Tamura K, Makino S, Araki Y, et al: Recombinant interferon beta and gamma in the treatment of adult T-cell leukemia. Cancer 59:1059\u20131062, 1987","journal-title":"Cancer"},{"key":"3_CR80","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/1097-0142(19910815)68:4<695::AID-CNCR2820680405>3.0.CO;2-K","volume":"68","author":"K Ezaki","year":"1991","unstructured":"Ezaki K, Hirano M, Ohno R, et al: A combination trial of human lymphoblastoid interferon and bestrabucil (KM2210) for adult T-cell leukemia,lymphoma. Cancer 68:695\u2013698, 1991","journal-title":"Cancer"},{"key":"3_CR81","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1182\/blood.V82.6.1701.1701","volume":"82","author":"TA Waldmann","year":"1993","unstructured":"Waldmann TA, White JD, Goldman CK, et al: The Interleukin-2 Receptor: A target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia. Blood 82:1701\u20131712, 1993","journal-title":"Blood"},{"key":"3_CR82","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood.V86.11.4063.bloodjournal86114063","volume":"86","author":"TA Waldmann","year":"1995","unstructured":"Waldmann TA, White JD, Carrasquillo JA, et al: Radioimmunotherapy of interleukin-2Ra-expressing adult T-cell leukemia with Yttriium-90-labeled anti-Tac. Blood 86:4063\u20134075, 1995","journal-title":"Blood"},{"key":"3_CR83","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1046\/j.1365-2141.1998.01068.x","volume":"103","author":"K Ishitsuka","year":"1998","unstructured":"Ishitsuka K, Hanada S, Suzuki S, et al: Arsenic trioxide inhibits growth of human T-cell leukemia virus type I infected T-cell lines more effectively than retinoic acids. Br J Hematol 103:721\u2013728, 1998","journal-title":"Br J Hematol"},{"issue":"S1","key":"3_CR84","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.1097\/00042560-199600001-00029","volume":"13","author":"GD The","year":"1996","unstructured":"The GD, Kazanji M: An HTLV-I,II vaccine: From animal models to clinical trials? J Acquir Immune Defic Hum Retrovirol 13(S1):S191\u2013S198, 1996","journal-title":"J Acquir Immune Defic Hum Retrovirol"},{"key":"3_CR85","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1089\/aid.1993.9.381","volume":"9","author":"GD The","year":"1993","unstructured":"The GD, Bomford R: An HTLV-I vaccine: Why, how, for whom? AIDS Res Hum Retrovirol 9:381\u2013386, 1993","journal-title":"AIDS Res Hum Retrovirol"},{"key":"3_CR86","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1073\/pnas.89.7.3005","volume":"89","author":"ZN Berneman","year":"1992","unstructured":"Berneman ZN, Gartenhaus RB, Reitz MS, et al: Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia,lymphoma and healthy carriers. Proc Nail Acad Sci 89: 3005\u20133009, 1992","journal-title":"Proc Nail Acad Sci"}],"container-title":["Cancer Treatment and Research","HIV &amp; HTLV-I Associated Malignancies"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-1601-9_3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T19:02:03Z","timestamp":1637694123000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-1601-9_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001]]},"ISBN":["9781461356356","9781461516019"],"references-count":86,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-1601-9_3","relation":{},"ISSN":["0927-3042"],"issn-type":[{"value":"0927-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2001]]}}}